HIV-1 Viremia Prevents the Establishment of Interleukin 2-producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity

Journal of Experimental Medicine

Volumn 198, Issue 12, 2003, Pages 1909-1922

  Younes, Souheil Antoine ^a   Yassine Diab, Bader ^a   Dumont, Alam R ^a,c   Boulassel, Mohamed Rachid ^b   Grossman, Zvi ^d   Routy, Jean Pierre ^b   Sékaly, Rafick Pierre ^a,b,c,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d TEL AVIV UNIVERSITY   (Israel)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

HAART; Primary HIV 1 infection; T cell memory; T cell proliferation

Indexed keywords

6 CARBOXYFLUORESCEIN; ABACAVIR; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CD4 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR7; DIDANOSINE; EFAVIRENZ; ESTER DERIVATIVE; GAG PROTEIN; GAMMA INTERFERON; INDINAVIR; INTERLEUKIN 2; LAMIVUDINE; NEF PROTEIN; NELFINAVIR; RITONAVIR; STAVUDINE; SUCCINIMIDE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CANADA; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; PRIORITY JOURNAL; TREATMENT FAILURE; VIREMIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIGENS, CD45; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; RECEPTORS, CHEMOKINE; VIREMIA;

EID: 0347911962     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031598     Document Type: Article

References (50)

1. Douek, D.C., L.J. Picker, and R.A. Koup. 2003. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21:265-304.
2. Pope, M., and A.T. Haase. 2003. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9:847-852.
3. + T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med. 8:319-323.
4. Mohri, H., A.S. Perelson, K. Tung, R.M. Ribeiro, B. Ramratnam, M. Markowitz, R. Kost, A. Hurley, L. Weinberger, D. Cesar, et al. 2001. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194:1277-1287.
5. Kovacs, J.A., R.A. Lempicki, I.A. Sidorov, J.W. Adetsberger, B. Herpin, J.A. Metcalf, I. Sereti, M.A. Polis, R.T. Davey, J. Tavel, et al. 2001. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194:1731-1741.
6. Mohri, H., S. Bonhoeffer, S. Monard, A.S. Perelson, and D.D. Ho. 1998. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science. 279:1223-1227.
7. +) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc. Natl. Acad. Sci. USA. 95:6388-6393.
8. Silvestri, G., D.L. Sodora, R.A. Koup, M. Paiardini, S.P. O'Neil, H.M. McClure, S.I. Staprans, and M.B. Feinberg. 2003. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity. 18:441-452.
9. Sousa, A.E., J. Carneiro, M. Meier-Schellersheim, Z. Grossman, and R.M. Victorino. 2002. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169:3400-3406.
10. Kalams, S.A., and B.D. Walker. 1998. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:2199-2204.
11. + T cell memory. Science. 297:2060-2063.
12. Bennett, S.R., F.R. Carbone, F. Karamalis, R.A. Flavell, J.F. Miller, and W.R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature. 393:478-480.
13. + T-helper and a T-killer cell. Nature. 393:474-478.
14. Schoenberger, S.P., R.E. Toes, E.I. van der Voort, R. Offringa, and C.J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:480-483.
15. + T cell responses associated with control of viremia. Science. 278:1447-1450.
16. + T cells. Nature. 417:95-98.
17. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518-525.
18. +) T cell proliferation. Proc. Natl. Acad. Sci. USA. 98:13878-13883.
19. +) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J. Virol. 76:5925-5936.
20. + T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J. Infect. Dis. 182:792-798.
21. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708-712.
22. Machado, D.M., E.L. Delwart, R.S. Diaz, C.F. de Oliveira, K. Alves, B.D. Rawal, M. Sullivan, M. Gwinn, K.A. Clark, and M.P. Busch. 2002. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS. 16:113-119.
23. Rogers, P.R., C. Dubey, and S.L. Swain. 2000. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J. Immunol. 164:2338-2346.
24. + T cells. J. Immunol. 164:265-272.
25. Novak, E.J., S.A. Masewicz, A.W. Liu, A. Lernmark, W.W. Kwok, and G.T. Nepom. 2001. Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset. Int. Immunol. 13:799-806.
26. Gudmundsdottir, H., A.D. Wells, and L.A. Turka. 1999. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 162:5212-3223.
27. +) T cell responses directed against influenza viral antigens postinfluenza vaccination. J. Immunol. 171:3163-3169.
28. Pontesilli, O., S. Kerkhof-Garde, N.G. Pakker, D.W. Notermans, M.T. Roos, M.R. Klein, S.A. Danner, and F. Miedema. 1999. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection. Immunol. Lett. 66:213-217.
29. Binley, J.M., D.S. Schiller, G.M. Ortiz, A. Hurley, D.F. Nixon, M.M. Markowitz, and J.P. Moore. 2000. The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy. J. Infect. Dis. 181:1249-1263.
30. Valentine, F.T., A. Paolino, A. Saito, and R.S. Holzman. 1998. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease. AIDS Res. Hum. Retroviruses. 14:S161-S166.
31. Plana, M., F. Garcia, T. Gallart, J.M. Miro, and J.M. Gatell. 1998. Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study. Lancet. 352:1194-1195.
32. Rinaldo, C.R., J.M. Liebmann, X.L. Huang, Z. Fan, Q. Al Shboul, D.K. McMahon, R.D. Day, S.A. Riddler, and J.W. Mellors. 1999. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J. Infect. Dis. 179:329-336.
33. Ghanekar, S.A., S.A. Stranford, J.C. Ong, J.M. Walker, V.C. Maino, and J.A. Levy. 2001. Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy. AIDS. 15:1885-1887.
34. Altfeld, M., E.S. Rosenberg, R., Shankarappa, J.S. Mukherjee, F.M. Hecht, R.L. Eldridge, M.M. Addo, S.H. Poon, M.N. Phillips, G.K. Robbins, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193:169-180.
35. + T lymphocytes. Proc. Natl. Acad. Sci. USA. 97:3382-3387.
36. Rosenberg, E.S., M. Altfeld, S.H. Poon, M.N. Phillips, B.M. Wilkes, R.L. Eldridge, G.K. Robbins, R.T. D'Aquila, P.J. Goulder, and B.D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature. 407:523-526.
37. +) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
38. Wilson, C.C., B. Palmer, S. Southwood, J. Sidney, Y. Higashimoto, E. Appella, R. Chesnut, A. Sette, and B.D. Livingston. 2001. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes. J. Virol. 75:4195-4207.
39. Champagne, P., G.S. Ogg, A.S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 410:106-111.
40. + T-cell responses containing replication of the primary virus. Nature. 420:434-439.
41. + T cells is associated with diminished IL-2 production and recovered by exogenous IL-2. J. Virol. 77:10900-10909.
42. Fuller, M.J., and A.J. Zajac. 2003. Ablation of CD8 and CD4 T cell responses by high viral loads. J. Immunol. 170:477-486.
43. + T cells upon acute versus persistent viral infection. Immunity. 9:449-457.
44. Reinhardt, R.L., A. Khoruts, R. Merica, T. Zell, and M.K. Jenkins. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature. 410:101-105.
45. Lanzavecchia, A., and F. Sallusto. 2002. Progressive differentiation and selection of the fittest in the immune response. Nat. Rev. Immunol. 2:982-987.
46. Kaech, S.M., E.J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
47. Grossman, Z., and W.E. Paul. 2000. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin. Immunol. 12:197-203.
48. Grossman, Z., M.B. Feinberg, and W.E. Paul. 1998. Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. USA. 95:6314-6319.
49. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75.
50. Blattman, J.N., J.M. Grayson, E.J. Wherry, S.M. Kaech, K.A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9:540-547.